Trends of Systemic Therapy Use for Renal Cell Carcinoma in the United States-Reference-Cited by-同舟云学术

Trends of Systemic Therapy Use for Renal Cell Carcinoma in the United States

Published:2015-06 Issue:6 Volume:85 Page:1399-1403
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Ferry Elizabeth K.,Minnillo Brian J.,Maurice Matthew J.,Abouassaly Robert,Zhu Hui

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Rising incidence of renal cell cancer in the United States;Chow;JAMA,1999

2. Epidemiology and risk factors for kidney cancer;Chow;Nat Rev Urol,2010

3. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010;King;J Urol,2014

4. Renal cell carcinoma;Motzer;N Engl J Med,1996

5. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma;Elson;Cancer Res,1988

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for metastatic renal cell carcinoma: A brief history, current trends, and future directions;Urologic Oncology: Seminars and Original Investigations;2021-10

2. Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma;Kidney Cancer;2020-09-16

3. Patient characteristics and treatments one year after diagnosis of renal cancer in 2015 according to the presence or absence of metastasis and a history of another tumour: A national observational study;Bulletin du Cancer;2019-06

4. The current treatment patterns of metastatic renal cell carcinoma: A national cancer database review, 2004–2015;Journal of Clinical Urology;2019-01-18

5. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma;Cancer Epidemiology;2018-06